Schizophrenia
📧 Sign up to get email alerts when something new happens for Schizophrenia.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2025-01-22FDA Approved: FLUPHENAZINE DECANOATE — Supplemental Application (Sagent Pharmaceuticals)
FDA approved a supplemental application for fluphenazine decanoate filed by Sagent Pharmaceuticals, resulting in updated labeling for this l…
-
FDA approval · 2025-01-22FDA Approved: FLUPHENAZINE HYDROCHLORIDE — Supplemental Application (ANI Pharmaceuticals, Inc.)
The FDA approved ANI Pharmaceuticals' supplemental application for fluphenazine hydrochloride, a generic antipsychotic used to treat schizop…
-
FDA approval · 2025-01-22FDA Approved: SAPHRIS — Supplemental Application (Allergan, Inc.)
The FDA approved Allergan's supplemental application for SAPHRIS (asenapine), resulting in changes to the product labeling.
-
FDA approval · 2025-01-22FDA Approved: PERPHENAZINE — Supplemental Application (Rising Pharma Holdings, Inc.)
The FDA approved a supplemental application for PERPHENAZINE filed by Rising Pharma Holdings, Inc.
-
FDA approval · 2025-01-22FDA Approved: FLUPHENAZINE HYDROCHLORIDE — Supplemental Application (Zameer Pharmaceuticals LLC)
The FDA approved a supplemental application for Fluphenazine Hydrochloride from Zameer Pharmaceuticals LLC (ANDA 215141), granting a supplem…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2025-01-22FDA Approved: MOLINDONE HYDROCHLORIDE — Supplemental Application (EPIC PHARMA, LLC)
FDA approved a supplemental application for Molindone Hydrochloride, a generic version of molindone hydrochloride, by Epic Pharma LLC.
-
FDA approval · 2025-01-22FDA Approved: SECUADO — Supplemental Application (Noven Therapeutics, LLC)
The FDA approved a supplemental application for SECUADO (asenapine) submitted by Noven Therapeutics, LLC.
-
FDA approval · 2025-01-22FDA Approved: ZYPREXA RELPREVV — Supplemental Application (H2-Pharma LLC)
The FDA approved a supplemental application for ZYPREXA RELPREVV (olanzapine pamoate) submitted by H2-Pharma LLC.
-
FDA approval · 2025-01-22FDA Approved: FANAPT — Supplemental Application (Vanda Pharmaceuticals Inc.)
FDA approved a supplemental application for FANAPT (iloperidone) from Vanda Pharmaceuticals Inc.
-
FDA approval · 2025-01-22FDA Approved: FLUPHENAZINE DECANOATE — Supplemental Application (Fresenius Kabi USA, LLC)
FDA approved a supplemental application for Fluphenazine decanoate by Fresenius Kabi USA, LLC, adding/confirming its approval as a long-acti…
-
FDA approval · 2025-01-22FDA Approved: GEODON — Supplemental Application (Viatris Specialty LLC)
The FDA approved a supplemental application for Geodon (ziprasidone) submitted by Viatris Specialty LLC.
-
FDA approval · 2025-01-22FDA Approved: FLUPHENAZINE HYDROCHLORIDE — Supplemental Application (Ajanta Pharma USA Inc.)
The FDA approved a supplemental application for fluphenazine hydrochloride from Ajanta Pharma USA Inc., approving changes to the already app…
-
FDA approval · 2025-01-22FDA Approved: PERPHENAZINE — Supplemental Application (Sandoz Inc)
FDA approved a supplemental application for PERPHENAZINE from Sandoz Inc. under ANDA 089685.
-
FDA approval · 2025-01-22FDA Approved: LOXAPINE — Supplemental Application (Actavis Pharma, Inc.)
The FDA approved a supplemental application for LOXAPINE by Actavis Pharma, Inc., resulting in updated labeling for the product.
-
FDA approval · 2025-01-22FDA Approved: RYKINDO EXTENDED-RELEASE MICROSPHERES — Supplemental Application (Shandong Luye Pharmaceutical Co., Ltd.)
The FDA approved a supplemental application for RYKINDO Extended-Release Microspheres (risperidone) from Shandong Luye Pharmaceutical Co., L…
-
FDA approval · 2025-01-22FDA Approved: HALOPERIDOL — Supplemental Application (AiPing Pharmaceutical, Inc)
FDA approved AiPing Pharmaceutical's supplemental application for haloperidol, a generic antipsychotic.
-
FDA approval · 2025-01-22FDA Approved: THIORIDAZINE HYDROCHLORIDE — Supplemental Application (Mylan Pharmaceuticals Inc.)
The FDA approved a supplemental application for thioridazine hydrochloride submitted by Mylan Pharmaceuticals Inc. for this generic antipsyc…
-
FDA approval · 2025-01-22FDA Approved: PERPHENAZINE — Supplemental Application (Zydus Pharmaceuticals (USA) Inc.)
The FDA approved a supplemental application for Perphenazine submitted by Zydus Pharmaceuticals (USA) Inc. under ANDA205232, enabling a gene…
-
FDA approval · 2025-01-22FDA Approved: FLUPHENAZINE HYDROCHLORIDE — Supplemental Application (Amneal Pharmaceuticals NY LLC)
FDA approved a supplemental application for Fluphenazine hydrochloride (generic) from Amneal Pharmaceuticals NY LLC. This is a supplemental …
-
FDA approval · 2025-01-22FDA Approved: PERPHENAZINE — Supplemental Application (Actavis Pharma, Inc.)
FDA approved a supplemental application for Perphenazine from Actavis Pharma, Inc. (ANDA207582) to support the generic product's availabilit…
-
FDA approval · 2025-01-22FDA Approved: PROCHLORPERAZINE MALEATE — Supplemental Application (ANI Pharmaceuticals, Inc.)
FDA approved ANI Pharmaceuticals, Inc.'s supplemental application for Prochlorperazine Maleate.
-
FDA approval · 2025-01-22FDA Approved: FLUPHENAZINE DECANOATE — Supplemental Application (Endo USA, Inc.)
FDA approved a supplemental application for Endo USA, Inc. to market Fluphenazine Decanoate, a long-acting injectable antipsychotic for schi…
-
FDA approval · 2025-01-22FDA Approved: FLUPHENAZINE HYDROCHORIDE — Supplemental Application (Rising Pharma Holdings, Inc.)
FDA approved a supplemental application for fluphenazine hydrochloride from Rising Pharma Holdings, Inc., under ANDA 218283.
-
FDA approval · 2025-01-22FDA Approved: CLOZAPINE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
The FDA approved a supplemental application for Clozapine submitted by Teva Pharmaceuticals USA, Inc.
-
FDA approval · 2025-01-22FDA Approved: THIORIDAZINE HYDROCHLORIDE — Supplemental Application (Chartwell RX, LLC)
FDA approved a supplemental application for thioridazine hydrochloride submitted by Chartwell RX, LLC.